2-(5-fluoro-pentyl)-2-methyl-malonic-acid

DB16029InvestigationalSmall molecule

2-(5-fluoro-pentyl)-2-methyl-malonic-acid is under investigation in clinical trial NCT00696943 (18F ML-10 for Early Detection of Response of Brain Metastases to SRS).

Formula / weight: C₉H₁₅FO₄ · 205.216 g/mol (avg)
Code names: 18F-ML-10 · ML-10 F-18

Resolves to

Compound

UNIIAK3K0K6CM5CAS1236354-10-1

Structure

InChIKeyBOYGOAXVKOOCKN-LMANFOLPSA-NSMILESCC(CCCCC[18F])(C(O)=O)C(O)=O

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of 2-(5-fluoro-pentyl)-2-methyl-malonic-acid, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account